SMYD4
SMYD4 (SET and MYND domain containing 4, also known as KIAA1936 or ZMYND21) is a protein-lysine N-methyltransferase that plays a critical role in cardiac development. It monomethylates PRMT5 and may also act on histones. Browse Assay Genie's current range of SMYD4 research reagents below, or read on for the biology behind the target.
SMYD4 is a protein-lysine N-methyltransferase. One of its characterised substrates is PRMT5, which it monomethylates, and this modification modulates the transcriptional activity of PRMT5. SMYD4 may also act as a histone methyltransferase. It is described as a key epigenetic regulator of gene expression during cardiac development, acting through two activities: as a methyltransferase and as a negative regulator of HDAC1.
The SMYD4 gene encodes a protein that belongs to the class V-like SAM-binding methyltransferase superfamily. HGNC places it in the zinc fingers MYND-type, SET domain containing and non-histone lysine methyltransferase gene groups, which reflects the domain architecture that gives the family its name. UniProt and NCBI Gene record the protein in both the nucleus and the cytoplasm. The mouse ortholog is Smyd4, which allows the biology of the SMYD4 gene to be studied in rodent models.
NCBI Gene summarises the protein as enabling protein-lysine N-methyltransferase activity and being involved in heart development. The gene has also been catalogued as KIAA1936 and ZMYND21. Its roles in non-histone methylation and in HDAC1 regulation make SMYD4 a useful subject for work on how lysine methylation links chromatin regulation to developmental gene expression. Related family members include SMYD1 and SMYD3.
SMYD4 plays a critical role in cardiac development and is involved in heart development, making it a focus for studies of cardiac gene regulation.
SMYD4 acts as an epigenetic regulator of gene expression through its methyltransferase activity and its negative regulation of HDAC1.
SMYD4 monomethylates PRMT5, modulating its transcriptional activity, which makes it a model for protein-lysine methylation beyond histones.
SMYD4 may also act as a histone methyltransferase, so its contribution to chromatin modification remains an open question for investigation.
SMYD4 is a protein-lysine N-methyltransferase. It monomethylates PRMT5, modulating its transcriptional activity, and may also methylate histones. It acts as an epigenetic regulator during cardiac development, using its methyltransferase activity and its role as a negative regulator of HDAC1.
The official HGNC name is SET and MYND domain containing 4, and UniProt lists the protein as Protein-lysine N-methyltransferase SMYD4. Aliases and previous symbols include KIAA1936 and ZMYND21. The enzyme is classed as EC 2.1.1.-, reflecting its methyltransferase activity.
A mouse ortholog, Smyd4, is recorded, so the gene can be studied in mouse models. SMYD4 is also linked to heart development in NCBI Gene annotation. Check the datasheet of any product for its validated reactivity.
Other SMYD family methyltransferases that share the SET and MYND domain architecture with SMYD4.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8IYR2; product specifications from Assay Genie datasheets.